City
Epaper

Indian pharma exports surged 90pc in last decade: Jitin Prasada

By IANS | Updated: August 28, 2024 14:40 IST

New Delhi, Aug 28 From $14.9 billion in FY14 Indian pharma exports have surged to $27.9 billion -- ...

Open in App

New Delhi, Aug 28 From $14.9 billion in FY14 Indian pharma exports have surged to $27.9 billion -- more than 90 per cent growth in the last 10 years, said Jitin Prasada, Union Minister of State (MoS) for Commerce and Industry on Wednesday.

He was speaking at the inauguration of a three-day International Exhibition For Pharma And Healthcare Exhibition (IPHEX 2024) organised by the Pharma Export Promotion Council of India (CAPEXIL) and the Ministry of Commerce and Industry in the national capital.

The MoS urged the Indian pharmaceutical industry to work towards becoming the healthcare custodian of the world.

“The Indian pharmaceutical sector is a significant contributor to the country's GDP and pharma exports are recovering to pre-pandemic growth levels, with over 9 per cent growth in FY24. From FY14 to FY24, exports surged from $14.9 billion to $27.9 billion, reflecting over 90 per cent growth,” Prasada said.

“With a current Indian market size of $50 billion including exports, the domestic pharma industry aims to expand to $120-130 billion by 2030 including exports, seizing emerging opportunities for growth,” he added.

While the country “is already recognised as the 'pharmacy of the world'”, the Minister called to focus not only “on strengths in the generic sector”, but also to “try product development, break new grounds".

“Focus on innovation, stress on quality, and work with the world market,” he said while stressing that international competitiveness is very important.

Prasada said that the recently concluded free trade agreements (FTAs) with various countries have helped create the pathway for easier approval for various products and bringing down tariffs.

“Hope the pharma industry will be able to use these new agreements for faster approvals. He also noted that the government has come up with many schemes like the production-linked incentive (PLI) for active pharmaceutical ingredients (APIs) and medical devices,” he added.

At the IPHEX 2024, more than 400 major Indian pharma companies will showcase their pharmaceutical products and technologies at the expo. More than 400 foreign buyers from across the world are expected to attend.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

InternationalEAM Jaishankar congratulates Singapore on 60th National Day, says "cherish enduring friendship"

BusinessTesla to open its second showroom in Delhi on August 11

TechnologyIndian Railways upgrading passenger reservation system to handle 1 lakh tickets per minute

Other SportsPaula Badosa withdraws from U.S. Open with recurring back injury

BusinessIndian Railways upgrading passenger reservation system to handle 1 lakh tickets per minute

Business Realted Stories

BusinessThe Art and Impact of Brand Storytelling

BusinessIndia’s LPG price is among lowest in world despite imports: Hardeep Puri

BusinessIndia negotiating trade pacts with several nations, including US: Piyush Goyal

BusinessPublic sector banks post record Rs 44,218 crore profit in Q1 FY26, SBI leads

BusinessAir India crash: 65 families from India and the UK hire US law firm